Page last updated: 2024-08-23

silybin and Kahler Disease

silybin has been researched along with Kahler Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Feng, N; Guo, X; Luo, J	1

Other Studies

1 other study(ies) available for silybin and Kahler Disease

Article	Year
Silybin suppresses cell proliferation and induces apoptosis of multiple myeloma cells via the PI3K/Akt/mTOR signaling pathway. Molecular medicine reports, 2016, Volume: 13, Issue:4 Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Chromones; Humans; Morpholines; Multiple Myeloma; Nuclear Proteins; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Signal Transduction; Silybin; Silymarin; TATA-Binding Protein Associated Factors; TOR Serine-Threonine Kinases	2016

Article

Year

Silybin suppresses cell proliferation and induces apoptosis of multiple myeloma cells via the PI3K/Akt/mTOR signaling pathway.

Molecular medicine reports, 2016, Volume: 13, Issue:4

Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Chromones; Humans; Morpholines; Multiple Myeloma; Nuclear Proteins; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Signal Transduction; Silybin; Silymarin; TATA-Binding Protein Associated Factors; TOR Serine-Threonine Kinases

2016